CARE Ratings Latest Share Price (CARERATING)
TODAY IN ONE LINE
CARERATING slipped 0.5% on above-average volume (2.1x avg), in line with Nifty's 0.5% move, supported by recent strong earnings.
With a market cap of ₹4,865.13 Cr., it trades at a P/E of 27.50. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
CARE Ratings flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 23.5% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 19.2% and Profit up 24.0%
- ●High Capital EfficiencyROCE of 26.3% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 19.7%
- ●Healthy Operating MarginsOPM is structurally strong at 41.7%
- ●Steady Dividend YieldReliable 1.31% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.03x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●FII SellingFII holding decreased by 1.01% QoQ
Latest CARE Ratings News
What changed recently?
Recent events, corporate actions, and announcements.
CARE Ratings Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for CARE Ratings Limited, framed against the sector median so the premium or discount is obvious at a glance.
CARE Ratings Limited trades at a P/E of 27.50× and P/B of 5.24×, against the Financial Services sector median P/E of 39.35×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
CARE Ratings Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for CARE Ratings Limited — derived from the latest tape, not yesterday's close.
CARE Ratings Limited last traded at ₹1,618.6 with an intraday range of ₹1,590.2–₹1,623 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1618.60| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1696.60 | +78.00 | +4.82% |
| R3 | 1663.80 | +45.20 | +2.79% |
| R2 | 1643.40 | +24.80 | +1.53% |
| R1 | 1631.00 | +12.40 | +0.77% |
| PIVOT | 1610.60 | -8.00 | -0.49% |
| CURRENT | 1618.60 | — | — |
| S1 | 1598.20 | -20.40 | -1.26% |
| S2 | 1577.80 | -40.80 | -2.52% |
| S3 | 1565.40 | -53.20 | -3.29% |
| S4 | 1532.60 | -86.00 | -5.31% |
CARERATING is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹1590.2–₹1622.9
Trading Inside opening range
CARE Ratings Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for CARE Ratings Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
CARE Ratings Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹4,865.13 Cr. and reported EPS of ₹57.24.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 402 | 473 ▲ 17.6% |
| Sales Growth YoY %Derived | 21.30% | 17.59% |
| Other Income | 51 | 55 ▲ 8.0% |
| Total Income | 453 | 528 ▲ 16.5% |
| Gross ProfitDerived | 402 | 473 ▲ 17.6% |
| Gross Margin %Derived | 100.00% | 100.00% |
| 247 | 276 ▲ 11.6% | |
| EBITDA (Operating Profit)Derived | 155 | 197 ▲ 27.1% |
| OPM %Derived | 38.61% | 41.73% |
| 14 | 17 ▲ 21.9% | |
| Profit Before Tax (PBT) | 192 | 235 ▲ 22.4% |
| 52 | 62 ▲ 18.0% | |
| Effective Tax %Derived | 27.18% | 26.20% |
| Total Profit for Period | 140 | 174 ▲ 24.1% |
| Less: Non-controlling Interests | 3 | 3 ▼ 8.8% |
| Net Profit (Owner's PAT)Derived | 137 | 171 ▲ 24.7% |
| Net Profit Margin %Derived | 34.11% | 36.18% |
| PAT Growth YoY %Derived | 36.52% | 24.73% |
| Earnings Per Share (EPS ₹) | 45.85 | 56.97 ▲ 24.3% |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 0.4% |
| Other Comprehensive Income (Net of Tax) | -0 | 3 ▲ 1085.1% |
| Total Expenses (incl. D&A & Interest) | 261 | 293 ▲ 12.2% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 46.96% | 45.38% |
| Other Cost % of RevenueDerived | 14.43% | 12.90% |
| Interest Coverage (x)Derived | 68.12x | 73.62x |
| Period | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 319 | 244 ▼ 23.6% | 248 ▲ 2.0% | 248 ▼ 0.3% | 279 ▲ 12.7% | 332 ▲ 18.9% | 402 ▲ 21.3% | 473 ▲ 17.6% | |
| Sales Growth YoY %Derived | — | -23.62% | 1.97% | -0.33% | 12.66% | 18.89% | 21.30% | 17.59% | |
| Other Income | 30 | 31 ▲ 3.5% | 31 ▼ 0.6% | 27 ▼ 13.1% | 38 ▲ 39.5% | 47 ▲ 23.1% | 51 ▲ 8.7% | 55 ▲ 8.0% | |
| Total Income | 349 | 275 ▼ 21.3% | 280 ▲ 1.7% | 275 ▼ 1.8% | 317 ▲ 15.3% | 378 ▲ 19.4% | 453 ▲ 19.7% | 528 ▲ 16.5% | |
| Gross ProfitDerived | 319 | 244 ▼ 23.6% | 248 ▲ 2.0% | 248 ▼ 0.3% | 279 ▲ 12.7% | 332 ▲ 18.9% | 402 ▲ 21.3% | 473 ▲ 17.6% | |
| Gross Margin %Derived | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
144 | 162 ▲ 12.5% | 153 ▼ 5.9% | 168 ▲ 10.1% | 180 ▲ 6.9% | 220 ▲ 22.2% | 247 ▲ 12.5% | 276 ▲ 11.6% | ||
| EBITDA (Operating Profit)Derived | 175 | 81 ▼ 53.4% | 96 ▲ 17.8% | 80 ▼ 16.9% | 99 ▲ 24.8% | 112 ▲ 12.9% | 155 ▲ 38.5% | 197 ▲ 27.1% | |
| OPM %Derived | 54.76% | 33.38% | 38.55% | 32.15% | 35.61% | 33.81% | 38.61% | 41.73% | |
3 | 9 ▲ 161.1% | 8 ▼ 3.2% | 8 ▼ 3.0% | 12 ▲ 41.1% | 12 ▲ 5.8% | 14 ▲ 13.4% | 17 ▲ 21.9% | ||
| Profit Before Tax (PBT) | 202 | 104 ▼ 48.4% | 119 ▲ 14.0% | 99 ▼ 16.9% | 126 ▲ 27.5% | 147 ▲ 16.6% | 192 ▲ 31.1% | 235 ▲ 22.4% | |
64 | 21 ▼ 67.6% | 28 ▲ 34.3% | 22 ▼ 21.2% | 40 ▲ 84.8% | 44 ▲ 9.4% | 52 ▲ 18.6% | 62 ▲ 18.0% | ||
| Effective Tax %Derived | 31.56% | 19.80% | 23.33% | 22.10% | 32.04% | 30.05% | 27.18% | 26.20% | |
| Total Profit for Period | 138 | 83 ▼ 39.5% | 91 ▲ 9.0% | 77 ▼ 15.5% | 85 ▲ 11.2% | 103 ▲ 20.0% | 140 ▲ 36.5% | 174 ▲ 24.1% | |
| Less: Non-controlling Interests | 1 | 1 ▲ 86.3% | 1 ▲ 30.7% | 2 ▲ 18.7% | 2 ▲ 13.0% | 2 ▲ 4.9% | 3 ▲ 35.5% | 3 ▼ 8.8% | |
| Net Profit (Owner's PAT)Derived | 137 | 82 ▼ 40.1% | 90 ▲ 8.7% | 75 ▼ 16.1% | 84 ▲ 11.2% | 101 ▲ 20.4% | 137 ▲ 36.5% | 171 ▲ 24.7% | |
| Net Profit Margin %Derived | 43.10% | 33.81% | 36.03% | 30.33% | 29.93% | 30.31% | 34.11% | 36.18% | |
| PAT Growth YoY %Derived | — | -40.08% | 8.68% | -16.10% | 11.19% | 20.37% | 36.52% | 24.73% | |
| Earnings Per Share (EPS ₹) | 46.66 | 27.96 ▼ 40.1% | 30.38 ▲ 8.7% | 25.33 ▼ 16.6% | 27.83 ▲ 9.9% | 33.67 ▲ 21.0% | 45.85 ▲ 36.2% | 56.97 ▲ 24.3% | |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.6% | 3 ▲ 0.2% | 3 ▲ 0.5% | 3 ▲ 0.3% | 3 ▲ 0.4% | |
| Other Comprehensive Income (Net of Tax) | -2 | -1 ▲ 58.1% | 2 ▲ 351.6% | 8 ▲ 261.9% | -1 ▼ 110.9% | -0 ▲ 71.5% | -0 ▼ 8.2% | 3 ▲ 1085.1% | |
| Total Expenses (incl. D&A & Interest) | 148 | 171 ▲ 15.8% | 161 ▼ 5.8% | 176 ▲ 9.4% | 191 ▲ 8.5% | 232 ▲ 21.2% | 261 ▲ 12.5% | 293 ▲ 12.2% | |
| Material Cost % of RevenueDerived | — | — | — | — | — | — | — | — | |
| Employee Cost % of RevenueDerived | 32.23% | 44.85% | 48.24% | 51.05% | 48.01% | 49.62% | 46.96% | 45.38% | |
| Other Cost % of RevenueDerived | 13.01% | 21.77% | 13.21% | 16.80% | 16.38% | 16.57% | 14.43% | 12.90% | |
| Interest Coverage (x)Derived | — | 79.30x | 142.46x | 155.03x | 88.66x | 59.37x | 68.12x | 73.62x |
CARE Ratings segment analysis : revenue and profit mix.
Disclosed business segments at CARE Ratings with their share of revenue and profit, switchable between consolidated and standalone reporting.
CARE Ratings discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for CARE Ratings Limited.
Our AI distills the core fundamental drivers supporting CARE Ratings Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
CARE Ratings Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating margin 38.81% demonstrates exceptional profitability and operational efficiency.
ROE 19.70% and ROCE 26.30% reflect highly efficient capital deployment and returns.
Debt-to-equity 0.0003 indicates minimal leverage and fortress-like financial stability.
Latest quarterly EPS grew 24.0% YoY, demonstrating robust earnings momentum.
TTM revenue grew 19.2% YoY, signaling strong top-line expansion and market demand.
Key Risks.
P/E ratio 29.13x trades at premium to sector median, suggesting stretched valuation.
Payout ratio 58.06% limits retained earnings for reinvestment and growth initiatives.
52-week price return flat at 0%, reflecting lack of recent stock price momentum.
High P/B ratio 5.42x signals premium valuation relative to book value.
Operating cash flow conversion gap suggests working capital management challenges.
Flip Conditions.
Valuation risk. a P/E above 36 (~0.9× the sector multiple of 39.4) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 15% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.66%.
CARE Ratings Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — CARE Ratings Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
CARE Ratings Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for CARE Ratings Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
CARE Ratings Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for CARE Ratings Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in CARE Ratings Limited stood at 61.2% of traded volume, against a 20-day average of 55.9%.
CARE Ratings announcements: results, concalls, ratings, M&A.
Filings CARE Ratings sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
CARE Ratings files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 147 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
CARE Ratings Limited has informed the Exchange about Reschedule of Investor Meet
Analysts/Institutional Investor Meet/Con. Call Updates
CARE Ratings Limited has informed the Exchange about Schedule of Investor Meet
Analysts/Institutional Investor Meet/Con. Call Updates
CARE Ratings Limited has informed the Exchange about Schedule of Investor Meet
Analysts/Institutional Investor Meet/Con. Call Updates
CARE Ratings Limited has informed the Exchange about Schedule of Investor meet
Analysts/Institutional Investor Meet/Con. Call Updates
CARE Ratings Limited has informed the Exchange about Schedule of Investor Meet
Investor decks & rating reports.
General Updates
Press Release
Press Release
General Updates
Press Release
CARE Ratings dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue CARE Ratings has declared, sequenced by announce and record date.
CARE Ratings corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About CARE Ratings Limited: business, sector, key facts.
What CARE Ratings Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
CARE Ratings Limited operates in the Ratings industry under the Financial Services sector, listed as NSE: CARERATING, BSE: 534804.
CARE Ratings Limited is a prominent credit rating agency operating within India and internationally. Its core business revolves around providing comprehensive creditworthiness assessments for a diverse range of financial instruments and entities. This encompasses a wide spectrum of services, enabling investors and other stakeholders to make informed decisions based on a thorough understanding of associated risks.
The company's rating services cover a vast array of financial products, including various debt instruments such as bank loans, bonds (both long-term and short-term), non-convertible debentures (NCDs), commercial papers, preference shares, and fixed deposits. They also rate more complex instruments like principal-protected market-linked debentures, subordinate debt, certificates of deposit (CDs) for banks, perpetual bonds, and hybrid instruments. Further extending their expertise, CARE Ratings provides ratings for mutual funds, structured finance arrangements, and insurance entities.
Beyond traditional credit ratings, CARE Ratings offers specialized services including recovery ratings, which assess the potential recovery value of defaulted debt. They also provide ratings for real estate investment trusts (REITs), infrastructure debt (infra EL), and public finance entities. The agency plays a vital role in the initial public offering (IPO) process, acting as a monitoring agency to ensure transparency and accuracy of information presented to potential investors.
Established in 1993 and headquartered in Mumbai, India, CARE Ratings Limited has a long history of providing crucial credit risk assessments. Formerly known as Credit Analysis and Research Limited, the company rebranded in June 2017 to its current name. The breadth of its services and its international reach solidify its position as a key player in the credit rating industry, providing essential information to support sound investment decisions and financial market stability.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
Questions investors ask about CARE Ratings Limited (CARERATING).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of CARE Ratings Limited (CARERATING)?
The current share price of CARE Ratings Limited (CARERATING) is ₹1,618.60. Today, the stock has declined by ₹7.40 (0.46%), trading in a range of ₹1,590.20 to ₹1,623.00. The stock opened at ₹1,614.00 with a trading volume of 74,984 shares.
02Is CARE Ratings Limited stock a good investment for long-term?
CARE Ratings Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹4,865.13 Cr., P/E ratio of 27.5, ROE of 19.7%, and ROCE of 26.3%. The dividend yield stands at 1.31%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of CARE Ratings Limited stock?
The 52-week high price of CARE Ratings Limited (CARERATING) is ₹1,838.00, while the 52-week low is ₹1,392.70. Currently trading at ₹1,618.60, the stock is 16.22% above its 52-week low and 11.94% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy CARE Ratings Limited stock at the current price?
Whether to buy CARE Ratings Limited stock at ₹1,618.60 depends on multiple factors. The stock is currently trading with a P/E ratio of 27.5 and P/B ratio of 5.24. Today's performance shows a loss of 0.46%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of CARE Ratings Limited and when is the next dividend?
CARE Ratings Limited offers a dividend yield of 1.31%, which means for every ₹100 invested at the current price of ₹1,618.60, you can expect to receive approximately ₹1.31 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of CARE Ratings Limited?
CARE Ratings Limited's key financial metrics include: P/E Ratio: 27.5, P/B Ratio: 5.24, ROE: 19.7%, ROCE: 26.3%, Dividend Yield: 1.31%, EPS: ₹57.24, Book Value: ₹310.33, and Debt-to-Equity: 0.03. The company's market cap stands at ₹4,865.13 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is CARE Ratings Limited stock performing today in the market?
CARE Ratings Limited stock opened at ₹1,614.00 and is currently trading at ₹1,618.60, showing a decline of ₹7.40 (0.46%). The intraday high is ₹1,623.00 and low is ₹1,590.20. The trading volume stands at 74,984 shares, indicating moderate market participation today.
08What is the P/E ratio of CARE Ratings Limited and what does it indicate?
CARE Ratings Limited has a Price-to-Earnings (P/E) ratio of 27.5, which means investors are willing to pay 27.50 for every ₹1 of earnings. With an EPS of ₹57.24, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about CARE Ratings Limited (CARERATING) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.